PMID- 37812780
OWN - NLM
STAT- MEDLINE
DCOM- 20231102
LR  - 20231103
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 176
IP  - 10
DP  - 2023 Oct
TI  - Would You Screen This Patient for Cognitive Impairment? : Grand Rounds Discussion 
      From Beth Israel Deaconess Medical Center.
PG  - 1405-1412
LID - 10.7326/M23-1808 [doi]
AB  - Dementia, according to the American Psychiatric Association's Diagnostic and 
      Statistical Manual of Mental Disorders, Fifth Edition, is defined by a 
      significant decline in 1 or more cognitive domains that interferes with a 
      person's independence in daily activities. Mild cognitive impairment (MCI) 
      differs from dementia in that the impairment is not sufficient to interfere with 
      independence. For the purposes of this discussion, cognitive impairment (CI) 
      includes both dementia and MCI. Various screening tests are available for CI. 
      These tests ask patients to perform a series of tasks that assess 1 or more 
      domains of cognitive function or ask a caregiver to report on the patient's 
      abilities. A positive result on a screening test does not equate to a diagnosis 
      of CI; rather, it should lead to additional testing to confirm the diagnosis. On 
      review of the evidence, the U.S. Preventive Services Task Force (USPSTF) 
      concluded in 2020 that the evidence was insufficient to assess the balance of 
      benefits and harms of screening for CI in older adults ("I statement"). The 
      USPSTF did clarify that although there is insufficient evidence, there may be 
      important reasons to identify CI. In this article, 2 experts review the available 
      evidence to answer the following questions: What screening tools are available, 
      and how effective are they in identifying patients with CI? What interventions 
      are available for patients found to have CI, to what extent do they improve 
      patient outcomes, and what, if any, negative effects occur? And, would they 
      recommend screening for CI, and why or why not?
FAU - Burns, Risa B
AU  - Burns RB
AD  - Division of General Medicine, Beth Israel Deaconess Medical Center, Harvard 
      Medical School, Boston, Massachusetts (R.B.B., Z.K.).
FAU - Barry, Michael J
AU  - Barry MJ
AUID- ORCID: 0000-0001-6508-7109
AD  - Division of General Internal Medicine, Massachusetts General Hospital, Boston, 
      Massachusetts (M.J.B.).
FAU - Blacker, Deborah
AU  - Blacker D
AUID- ORCID: 0000-0001-6107-7376
AD  - Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, 
      Boston, Massachusetts (D.B.).
FAU - Kanjee, Zahir
AU  - Kanjee Z
AUID- ORCID: 0000-0001-9287-4503
AD  - Division of General Medicine, Beth Israel Deaconess Medical Center, Harvard 
      Medical School, Boston, Massachusetts (R.B.B., Z.K.).
LA  - eng
PT  - Journal Article
DEP - 20231010
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Teaching Rounds
MH  - *Cognitive Dysfunction/diagnosis
MH  - Mass Screening
MH  - Cognition
MH  - *Dementia/diagnosis
COIS- Disclosures: All relevant financial relationships have been mitigated. 
      Disclosures can also be viewed at 
      www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M23-1808.
EDAT- 2023/10/09 18:42
MHDA- 2023/11/02 12:45
CRDT- 2023/10/09 17:03
PHST- 2023/11/02 12:45 [medline]
PHST- 2023/10/09 18:42 [pubmed]
PHST- 2023/10/09 17:03 [entrez]
AID - 10.7326/M23-1808 [doi]
PST - ppublish
SO  - Ann Intern Med. 2023 Oct;176(10):1405-1412. doi: 10.7326/M23-1808. Epub 2023 Oct 
      10.